The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
- PMID: 31578522
- PMCID: PMC6858566
- DOI: 10.1038/s41586-019-1608-2
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
Abstract
Bacterial dysbiosis accompanies carcinogenesis in malignancies such as colon and liver cancer, and has recently been implicated in the pathogenesis of pancreatic ductal adenocarcinoma (PDA)1. However, the mycobiome has not been clearly implicated in tumorigenesis. Here we show that fungi migrate from the gut lumen to the pancreas, and that this is implicated in the pathogenesis of PDA. PDA tumours in humans and mouse models of this cancer displayed an increase in fungi of about 3,000-fold compared to normal pancreatic tissue. The composition of the mycobiome of PDA tumours was distinct from that of the gut or normal pancreas on the basis of alpha- and beta-diversity indices. Specifically, the fungal community that infiltrated PDA tumours was markedly enriched for Malassezia spp. in both mice and humans. Ablation of the mycobiome was protective against tumour growth in slowly progressive and invasive models of PDA, and repopulation with a Malassezia species-but not species in the genera Candida, Saccharomyces or Aspergillus-accelerated oncogenesis. We also discovered that ligation of mannose-binding lectin (MBL), which binds to glycans of the fungal wall to activate the complement cascade, was required for oncogenic progression, whereas deletion of MBL or C3 in the extratumoral compartment-or knockdown of C3aR in tumour cells-were both protective against tumour growth. In addition, reprogramming of the mycobiome did not alter the progression of PDA in Mbl- (also known as Mbl2) or C3-deficient mice. Collectively, our work shows that pathogenic fungi promote PDA by driving the complement cascade through the activation of MBL.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures
Comment in
-
Fungi accelerate pancreatic cancer.Nature. 2019 Oct;574(7777):184-185. doi: 10.1038/d41586-019-02892-y. Nature. 2019. PMID: 31591542 No abstract available.
-
Fungi complements cancer.Nat Rev Cancer. 2019 Dec;19(12):665. doi: 10.1038/s41568-019-0218-5. Nat Rev Cancer. 2019. PMID: 31616076 No abstract available.
-
Fungi promote pancreatic cancer.Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):706-707. doi: 10.1038/s41575-019-0231-x. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31636398 No abstract available.
-
Of fungi and men: role of fungi in pancreatic cancer carcinogenesis.Ann Transl Med. 2020 Oct;8(19):1257. doi: 10.21037/atm-20-2723. Ann Transl Med. 2020. PMID: 33178789 Free PMC article. No abstract available.
-
Revisiting the intrinsic mycobiome in pancreatic cancer.Nature. 2023 Aug;620(7972):E1-E6. doi: 10.1038/s41586-023-06292-1. Epub 2023 Aug 2. Nature. 2023. PMID: 37532819 Free PMC article.
Similar articles
-
Fungi, host immune response, and tumorigenesis.Am J Physiol Gastrointest Liver Physiol. 2021 Aug 1;321(2):G213-G222. doi: 10.1152/ajpgi.00025.2021. Epub 2021 Jul 7. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 34231392 Free PMC article. Review.
-
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.Nature. 2016 Apr 14;532(7598):245-9. doi: 10.1038/nature17403. Epub 2016 Apr 6. Nature. 2016. PMID: 27049944 Free PMC article.
-
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.Mol Immunol. 2011 Sep;48(15-16):2009-18. doi: 10.1016/j.molimm.2011.06.215. Epub 2011 Jul 1. Mol Immunol. 2011. PMID: 21723612 Free PMC article.
-
Mycobiome and Cancer: What Is the Evidence?Cancers (Basel). 2021 Jun 24;13(13):3149. doi: 10.3390/cancers13133149. Cancers (Basel). 2021. PMID: 34202433 Free PMC article. Review.
-
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment.Curr Oncol. 2022 Dec 14;29(12):9833-9854. doi: 10.3390/curroncol29120773. Curr Oncol. 2022. PMID: 36547187 Free PMC article. Review.
Cited by
-
Microbiota in tumors: new factor influencing cancer development.Cancer Gene Ther. 2024 Sep 28. doi: 10.1038/s41417-024-00833-0. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39342031 Review.
-
Effect of diet on the gut mycobiome and potential implications in inflammatory bowel disease.Gut Microbes. 2024 Jan-Dec;16(1):2399360. doi: 10.1080/19490976.2024.2399360. Epub 2024 Sep 17. Gut Microbes. 2024. PMID: 39287010 Free PMC article. Review.
-
Microbiome-Stealth Regulator of Breast Homeostasis and Cancer Metastasis.Cancers (Basel). 2024 Aug 31;16(17):3040. doi: 10.3390/cancers16173040. Cancers (Basel). 2024. PMID: 39272898 Free PMC article. Review.
-
Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment.Discov Oncol. 2024 Sep 13;15(1):443. doi: 10.1007/s12672-024-01320-6. Discov Oncol. 2024. PMID: 39271584 Free PMC article.
-
Barriers and opportunities in pancreatic cancer immunotherapy.NPJ Precis Oncol. 2024 Sep 12;8(1):199. doi: 10.1038/s41698-024-00681-z. NPJ Precis Oncol. 2024. PMID: 39266715 Free PMC article. Review.
References
-
- Pushalkar S et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov 8, 403–416, doi:10.1158/2159-8290.CD-17-1134 (2018). - DOI - PMC - PubMed
-
- Hingorani SR et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer cell 4, 437–450 (2003). - PubMed
-
- van Asbeck EC, Hoepelman AI, Scharringa J, Herpers BL & Verhoef J Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol 8, 229, doi:10.1186/1471-2180-8-229 (2008). - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous